Stay updated on Cevostamab Safety & Activity in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Cevostamab Safety & Activity in Multiple Myeloma Clinical Trial page.

Latest updates to the Cevostamab Safety & Activity in Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedAdded a new Revision: v3.3.3 entry. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page history now includes a new revision entry Revision: v3.3.2, replacing v3.3.1, which is a minor metadata update to the revision list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedThe record history shows a new revision (v3.3.1) and removal of a previous revision (v3.2.0), which are version-tracking updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved a government funding status notice across the page, with no impact on study data, eligibility, or navigation. The layout remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedThe new screenshot shows an updated version of the record with changes to the study status and recruitment details for CAMMA 1 (NCT04910568). The layout remains similar, but the updated entries reflect progress in the trial.SummaryDifference0.1%

- Check76 days agoChange DetectedUpdate adds a new study status section with contacts/locations and a new date entry, while removing an older dated item to reflect current information.SummaryDifference0.7%

Stay in the know with updates to Cevostamab Safety & Activity in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cevostamab Safety & Activity in Multiple Myeloma Clinical Trial page.